Skip to main content

Articles

Recent Articles

ICH M10: History, publication and initial perspectives on global implementation
Articles  —  13 December Dec 2023

ICH M10: History, publication and initial perspectives on global implementation

Read More about ICH M10: History, publication and initial perspectives on global implementation
Empowering development and enabling seamless assay transfer
Articles  —  13 December Dec 2023

Empowering development and enabling seamless assay transfer

Read More about Empowering development and enabling seamless assay transfer
Driving efficient immuno-oncology drug development with optimal preclinical model selection
Articles  —  13 December Dec 2023

Driving efficient immuno-oncology drug development with optimal preclinical model selection

Read More about Driving efficient immuno-oncology drug development with optimal preclinical model selection
Giving the gift of gratitude
Articles  —  11 December Dec 2023

Giving the gift of gratitude

Read More about Giving the gift of gratitude
Giving the gift of gratitude
Articles  —  11 December Dec 2023

Giving the gift of gratitude

Read More about Giving the gift of gratitude
Increasing the likelihood of biosimilar success with chemistry, manufacturing and control
Articles  —  8 December Dec 2023

Increasing the likelihood of biosimilar success with chemistry, manufacturing and control

Read More about Increasing the likelihood of biosimilar success with chemistry, manufacturing and control
Increasing the likelihood of biosimilar success with chemistry, manufacturing and control
Articles  —  8 December Dec 2023

Increasing the likelihood of biosimilar success with chemistry, manufacturing and control

Read More about Increasing the likelihood of biosimilar success with chemistry, manufacturing and control
OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial
Articles  —  7 December Dec 2023

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Read More about OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial
Top considerations for developing a biomarker solution and CDx strategy
Articles  —  7 December Dec 2023

Top considerations for developing a biomarker solution and CDx strategy

Read More about Top considerations for developing a biomarker solution and CDx strategy
Potency assays 101: How to develop a CMC relative potency assay
Articles  —  7 December Dec 2023

Potency assays 101: How to develop a CMC relative potency assay

Read More about Potency assays 101: How to develop a CMC relative potency assay
Potency assays 101: How to develop a CMC relative potency assay
Articles  —  7 December Dec 2023

Potency assays 101: How to develop a CMC relative potency assay

Read More about Potency assays 101: How to develop a CMC relative potency assay
OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial
Articles  —  7 December Dec 2023

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Read More about OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial